Disainilahendus CureSight Laisasilma Raviseade, autor Kobi Kor

Disainilahendus CureSight Laisasilma Raviseade, mille autor on Kobi Kor, on kõrgelt hinnatud 2022 auhinna Rauaauhind A' Design Award võitja konkursi kategoorias Meditsiiniseadmete ja -aparatuuri disain.

RaudMeditsiinitoode· 2022

CureSight Laisasilma Raviseade

disainer: Kobi Kor

Klient: Novasight

Auhind Rauaauhind A' Design Award kategoorias Meditsiinitoode

22,237

Kinnitatud auhinna võitja

Kinnita auhinna staatus disainile #133911

Avasta kohe Külasta lehte Vaata A' Design Award lehel Pressiteade Auhinna märgis

Värvid

Disain

Teosest CureSight Laisasilma Raviseade

CureSighti disainiprotsess keskendus toote ja ravilahenduse loomisele, mis avaldab positiivset sotsiaalset mõju ja aitab patsientidel, kellest enamik on lapsed, vältida ebamugavust ja piinlikkust, mis kaasneb traditsioonilise silmaplaastri raviga. Disainis rõhutatakse ka seda, et toote välimus ja tunnetus on laste motiveerimiseks ja võimendamiseks hädavajalikud. Stiilikujunduse inspiratsioon tuli tehnilistest vidinatest, mida lapsed armastavad seda kasutada ja nendega mängida. Kujuline disain annab meditsiiniseadme tootele libeda ja kaasaegse välimuse.

Tunnustus

Auhinnast Rauaauhind A' Design Award

CureSight Laisasilma Raviseade on Rauaauhinna A' Design Award võitja, prestiižikas tunnustus, mis antakse headele disainidele, mis vastavad professionaalsetele ja tööstuslikele nõuetele, mida oodatakse hästi disainitud töödelt. Raudvõitjad näitavad oma loojate suurt oskust, kõrget spetsialiseerumist, asjatundlikku mõistmist ja loomingulist võimekust. CureSight Laisasilma Raviseade peaks olema kõrgelt hinnatud, imetletud ja armastatud looming, mis on praktiline ja uuenduslik. See Rauaauhinna A' Design Award võidudisain ühendab tööstuse parimaid tavasid ning tal on pädevad tehnilised omadused, mis on seotud oskusteabe ja andega. CureSight Laisasilma Raviseade on austatud oma põhjalikkuse eest ning on loodud pakkuma elukvaliteedi parandusi, mis aitavad teha maailma paremaks paigaks.

Disaini taustal

Pressimaterjalid

Disaineri esitatud autorid, meeskonnaliikmed ja tehnilised andmed.

Unikaalsed omadused: The curesight is a powerful solution with great potential to totally change the treatment of lazy eye condition, with the important advantage of treating the lazy eye from the comfort of home and by watching any tv or streaming video content.
This healthcare solution for lazy eye condition integrates high-end technologies for eye-tracking and ai software tools for smart analyzing of the lazy eye condition and providing personal custom treatment. The gold standard care for lazy eye is placing a patch over the strong eye, an old-fashioned solution that suffers from very low compliance.
Mõõtmed ja pakend: product net dimensions
Height 230mm
Width 390mm
Depth 60mm
Sildid: amlyopia, lazy eye, medical device, product design, social impact, degital healthcare
Tootmistehnoloogia: The design activity started with a brainstorming meeting to learn more about the problem from the clinical and user needs aspects, and to outline the main big limitations of today's treatment methods.
We also discussed the ergonomics and usability needs to be able to provide the best treatment.
during the design process, we tested several design concepts both aesthetically and with physical mockups,
Production technologies include aluminum CNC machining and anodize plating, for the front bezel and plastic injection for the back cover and small covers.
Disainiülesanne: The creative challenge was to dress the unique technology components with style and to provide a good user experience to the users, the specific usability needs to enable good treatment for various populations and make it an appealing and empowering treatment device, and lead to important social impact
Uurimistöö: Following an intense effort over the last 18 months, the company officially announced that the company successfully met the primary endpoint of the CureSight randomized, controlled pivotal trial of amblyopia treatment against the gold standard patching.
This is the first-ever pivotal study in which a digital device was shown to be non-inferior to eye patching for amblyopia treatment in children.
The study also exhibited 93% adherence to the curesight treatment, as well as a 93% likelihood of the parents choosing curesight over patching.
Inspiratsioon: The inspiration for the curesight product started from a personal experience when one of my kids needed to treat the lazy eye condition with the eye patch solution, I learned from this experience about the discomfort of wearing the eye patch for a few hours every day and especially how embarrassing it is from the social point of view.
The inspiration for the styling design came from the tech gadgets that kids love to use and play with, to provide a slick and modern design to a medical device product type, the front aluminum bezel, and the back swallowtail gives the product a clean gadget look.
Projekti kestus: The project started in 2019 in Tel Aviv, and finished in late 2021, the project was exhibited at the CES in January 2020 in Las Vegas
Tööprotsess: The patient, most likely kids will have the fun be treated by the Curesight while watching any video content they love to watch without any degradation in quality and from the comfort of home.
Meeskonnaliikmed: Kobi Kor
Tal Samet
Piltide autorid: All images
Photograph and Illustrations: Novasight and Kobi Kor